(Q24246510)

English

High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer

scientific article

In more languages

Statements

scholarly article

0 references

0 references

1 reference

Europe PubMed Central

High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer (English)

0 references

0 references

1 reference

based on heuristic

inferred from title

1

0 references

Jane Marjoribanks

2

0 references

4

0 references

author name string

Russell Basser

3

0 references

publication date

20 July 2005

0 references

Cochrane Database of Systematic Reviews

0 references

Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

21 January 2018

Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

21 January 2018

High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

21 January 2018

Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

21 January 2018

Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

21 January 2018

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

21 January 2018

Randomized trial of high-dose chemotherapy and hematopoietic progenitor-cell support in operable breast cancer with extensive lymph node involvement: final analysis with 7 years of follow-up

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

21 January 2018

Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

21 January 2018

High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

21 January 2018

Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

21 January 2018

High dose chemotherapy and autologous stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes involved: long-term results of an international randomised trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

21 January 2018

Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase III trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

21 January 2018

Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

21 January 2018

High-dose chemotherapy with autologous bone marrow transplantation for the treatment of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

21 January 2018

Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

21 January 2018

Status of high-dose chemotherapy for breast cancer: a review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

21 January 2018

High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

21 January 2018

Management and survival of female breast cancer: results of a national survey by the American College of Surgeons

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose: a critical factor in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimates of cancer incidence and mortality in Europe in 1995

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy for breast cancer: the French PEGASE experience

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003139.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD003139.PUB2

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24246510&oldid=1475301256"